Originally posted by smallcapper95
hi guys,
thought I'd start a thread to see what worries or concerns people have on Immuron? Forums are usually extremely bullish and only usually only focus on the positives, whereas it can often be constructive to discuss the concerns.
For me the obvious one is poor test results on NASH, this seems to be what most are bullish about. However the low share price indicates successful NASH results aren't overly priced in. I do think the share price would still take a bit however with any bad news..
That being said I still think the company is worth more than it is right now on its Travelan alone. Granted, it will take years to grow and commercialise the product and for the sales to correlate to increased share price. That's also a concern as impatient investors jump off board.
The next one that keeps popping Is managements abilIty.. a good product is only half the battle.
Opening the floor for any other concerns people have on Immuron..
Originally posted by smallcapper95
hi guys,
thought I'd start a thread to see what worries or concerns people have on Immuron? Forums are usually extremely bullish and only usually only focus on the positives, whereas it can often be constructive to discuss the concerns.
For me the obvious one is poor test results on NASH, this seems to be what most are bullish about. However the low share price indicates successful NASH results aren't overly priced in. I do think the share price would still take a bit however with any bad news..
That being said I still think the company is worth more than it is right now on its Travelan alone. Granted, it will take years to grow and commercialise the product and for the sales to correlate to increased share price. That's also a concern as impatient investors jump off board.
The next one that keeps popping Is managements abilIty.. a good product is only half the battle.
Opening the floor for any other concerns people have on Immuron..
The NASH results seemed promising but did not blow me away ... more of an incremental improvement at Ph 2 which is good but not great. Travelan might be best farmed out to a multinational for cash and royalties .. will take a long time for the brand to build ... or do the other route and use the proceeds to built Travelan ... both might be challenging given the need for cash to meet the burn rate. Raising more a ways back would have been smarter. There is a good balance on the board here but a few do seem to love the stock and are a bit silly with their options projections.
(20min delay)